Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide HFA in Seasonal Allergic Rhinitis
NCT00807053Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2007
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ciclesonide in seasonal allergic rhinitis (SAR), sponsored by AstraZeneca. Started Apr 2007; status: completed.
02
Drugs
ciclesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00807053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807053.